Nicolas Boissel - Concepedia

Author

Nicolas Boissel

Also Known As

N BOISSEL, N Boissel, N. Boissel, NICOLAS BOISSEL, Nicolas BOISSEL, Nicolas Boissel, Nicolas Duployez, Nolwenn Boissel, Rathana Kim

506

Publications

22.6K

Citations

H-Index

134

Concepts

All Affiliations

Hôpital Saint-Louis Assistance Publique – Hôpitaux de Paris Université Paris Cité Inserm Sorbonne Université

About

Nicolas Boissel is an author at Hôpital Saint-Louis specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	53	5K
2	Health Sciences	14	16	2.1K
3	Engineering	2	2	86
4	Natural Sciences	2	2	156
5	Public Health	1	1	36

Nicolas Boissel

165

Publications

18.3K

Citations

H-Index

Page 1

	Year	Citations
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner, New England Journal of Medicine	2018	5.4K
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study Bijal Shah, Armin Ghobadi, Olalekan O. Oluwole, The Lancet Hematological MalignancyLymphoid NeoplasiaMedicineImmunologyHematology	2021	721
Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA) Claude Preudhomme, C. Sagot, Nicolas Boissel, Blood	2002	503
Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome–Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study Giovanni Martinelli, Nicolas Boissel, Patrice Chevallier, Journal of Clinical Oncology	2017	437
Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML) Nicolas Boissel, Harmony Leroy, Benoît Brethon, Leukemia Ras Gene MutationsTumor BiologyHematological MalignancyPrognostic ImpactMedicine	2006	355
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia Éric Jourdan, Nicolas Boissel, Sylvie Chevret, Blood	2013	350
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies Reuben Benjamin, Charlotte Graham, Deborah Yallop, The Lancet Hematological MalignancyCell TherapyTransplantationMedicineHematology	2020	344
Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia Sébastien Maury, Sylvie Chevret, Xavier Thomas, New England Journal of Medicine	2016	340
A landscape of germ line mutations in a cohort of inherited bone marrow failure patients Olivier Bluteau, Marie Sébert, Thierry Leblanc, Blood	2017	333
Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia Kheïra Beldjord, Sylvie Chevret, Vahid Asnafi, Blood	2014	326

Page 1